Our comprehensive portfolio of upstream process chemicals not only provides biopharmaceutical manufacturers with high-quality raw materials for classical and novel therapies, but also helps them get to market faster and simplify regulatory challenges. You can rely on our cell culture media, purification, and clean-in-place products for consistent performance at every stage, from research to commercial application. Equally important, you can trust us to deliver supply chain transparency and reliable sourcing around the globe, streamlining your product qualification with best-in-class regulatory support and service.
Controlled manufacturing processes, optimized quality attributes, and precise analytical specifications make our raw materials well-suited for commercial biopharma processing. Now they go even further to simplify your qualification and risk assessment, as part of our industry-leading Emprove® Chemicals portfolio. All raw and starting materials are organized into categories to streamline selection, with each product offering the comprehensive, up-to-date documentation you need to navigate regulatory challenges, manage risks, and improve processes.
To help you meet increasing industry demands for faster, more flexible bioprocessing, we can supply raw materials in pre-filled bulk powder transfer bags of 1–100 kg for operations of every scale. Bags are pre-weighed to within +/-0.5% accuracy, eliminating potential for error and connecting directly to your receiving vessel for mitigation of risks associated with contamination and employee safety. This service is one of many examples that set us apart as a partner committed to your process efficiency and quality, offering potential to eliminate labor-intensive steps such as rinsing, re-weighing, and cleanup from your buffer and media prep.
Investigación. Desarrollo. Producción.
Somos un proveedor líder para la industria de Ciencias de la Vida con soluciones y servicios para investigación, desarrollo y producción biotecnológicos, y para desarrollo y producción de tratamientos farmacéuticos
© 2021 Merck KGaA, Darmstadt, Alemania y/o sus filiales. Todos los derechos reservados.